Altamira Therapeutics Ltd.
CYTOF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001601936
No open-market purchases or sales by Altamira Therapeutics Ltd. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Altamira Therapeutics Ltd. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 15 | 7 | −8 |
| Shares | 418.3K | 7.14K | −411.2K (−98.3%) |
| Value | $119.0K | $34.5K | −$84.5K (−71.0%) |
New holders (0)
Institutions that held Altamira Therapeutics Ltd. at the end of Q4 2022 but not at the end of Q3 2022.
None.
Sold out (8)
Institutions that held Altamira Therapeutics Ltd. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Virtu Financial LLC | 124,787 | $36.0K |
| Citadel Advisors LLC | 64,820 | $19.0K |
| Two Sigma Securities, LLC | 23,303 | $7.00K |
| Renaissance Technologies LLC | 19,946 | $6.00K |
| HRT Financial LP | 23,415 | $6.00K |
| Geode Capital Management, LLC | 18,871 | $5.00K |
| Simplex Trading, LLC | 7,552 | $2.00K |
| Bank of America Corp | 5 | $0 |